News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,299 Results
Type
Article (53124)
Company Profile (292)
Press Release (680883)
Section
Business (215565)
Career Advice (2853)
Deals (37297)
Drug Delivery (97)
Drug Development (85767)
Employer Resources (179)
FDA (16976)
Job Trends (15848)
News (365973)
Policy (35504)
Tag
Academia (2906)
Africa (923)
Alliances (52522)
Alzheimer's disease (1231)
Approvals (16885)
Arizona (183)
Artificial intelligence (75)
Asia (41721)
Australia (7563)
Bankruptcy (376)
Best Places to Work (11848)
Biosimilars (68)
Biotechnology (206)
C2C Services and Suppliers (84835)
California (1940)
Canada (946)
Cancer (538)
Career advice (2391)
Cell therapy (139)
China (155)
Clinical research (67065)
Collaboration (149)
Colorado (83)
Compensation (81)
Connecticut (75)
COVID-19 (2696)
Cystic fibrosis (76)
Data (321)
Diabetes (87)
Diagnostics (6334)
Drug pricing (77)
Earnings (85786)
Employer resources (153)
Europe (93046)
Events (114674)
Executive appointments (161)
FDA (17209)
Florida (271)
Funding (155)
Gene therapy (106)
Georgia (67)
GLP-1 (591)
Government (4736)
Healthcare (19964)
Hotbed/Location (502401)
Illinois (284)
Indiana (155)
Infectious disease (2727)
Inflammatory bowel disease (101)
Interviews (552)
IPO (16698)
Job creations (4133)
Job search strategy (1989)
Kansas (96)
Layoffs (440)
Legal (8697)
Lung cancer (123)
Manufacturing (98)
Maryland (423)
Massachusetts (1572)
Medical device (13755)
Medtech (13760)
Mergers & acquisitions (20450)
Metabolic disorders (279)
Michigan (127)
Minnesota (227)
Neuroscience (1398)
New Jersey (600)
New York (610)
NextGen Class of 2024 (7119)
Non-profit (4890)
North Carolina (645)
Northern California (841)
Obesity (168)
Ohio (106)
Opinion (214)
Patents (81)
Pennsylvania (587)
People (60684)
Phase I (20705)
Phase II (29404)
Phase III (22082)
Pipeline (114)
Postmarket research (2926)
Preclinical (8884)
Press Release (71)
Rare diseases (140)
Real estate (6440)
Recruiting (70)
Regulatory (23082)
Research institute (2561)
Resumes & cover letters (452)
South America (1302)
Southern California (781)
Startups (3868)
Texas (245)
United States (8913)
Vaccines (541)
Washington State (262)
Weight loss (155)
Date
Today (107)
Last 7 days (633)
Last 30 days (2534)
Last 365 days (38734)
2024 (27356)
2023 (41655)
2022 (52888)
2021 (57591)
2020 (56511)
2019 (49795)
2018 (37698)
2017 (34573)
2016 (34528)
2015 (40569)
2014 (34497)
2013 (29919)
2012 (31977)
2011 (32551)
2010 (30665)
734,299 Results for "hanger inc formerly known as hanger orthopedic group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Hanger Announces Pete Stoy as CEO
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced Pete Stoy, formerly the company’s President and Chief Operating Officer, has assumed the role of Hanger’s Chief Executive Officer, effective immediately.
May 1, 2023
·
2 min read
Deals
Hanger, Inc. Stockholders Approve Acquisition by Patient Square Capital
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm.
September 30, 2022
·
6 min read
Business
Hanger Announces CEO Transition Plan
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced Chairman and Chief Executive Officer Vinit Asar will retire from the role of CEO effective May 1, 2023 after more than a decade in the position.
January 18, 2023
·
3 min read
Deals
Hanger, Inc. Completes Acquisition by Patient Square Capital
Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction.
October 3, 2022
·
6 min read
Press Releases
The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share
September 13, 2024
·
1 min read
Pharm Country
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.
May 29, 2024
·
3 min read
BioMidwest
First Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal
Stratasys Ltd. and Ricoh USA, Inc. announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.
June 26, 2024
·
5 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
BioMidwest
First patient enrolled in landmark clinical study to assess 3D printed models for orthopedic tumor removal
Ricoh USA, Inc. and Stratasys Ltd. (NASDAQ: SSYS) today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.
June 26, 2024
·
5 min read
Pharm Country
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.
March 4, 2024
·
3 min read
1 of 73,430
Next
